These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and rats. Jodrell DI; Newell DR; Gibson W; Hughes LR; Calvert AH Cancer Chemother Pharmacol; 1991; 28(5):331-8. PubMed ID: 1914075 [TBL] [Abstract][Full Text] [Related]
23. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
24. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
25. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
26. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
27. Disposition of 5-methyltetrahydrohomofolate in mice, dogs, and monkeys. El Dareer SM; Tillery KF; Hill DL Cancer Treat Rep; 1979 Feb; 63(2):201-7. PubMed ID: 109197 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572 [TBL] [Abstract][Full Text] [Related]
29. Disposition and metabolism of finasteride in dogs. Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636 [TBL] [Abstract][Full Text] [Related]
30. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase. Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414 [TBL] [Abstract][Full Text] [Related]
31. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats. Timchalk C; Smith FA; Bartels MJ Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263 [TBL] [Abstract][Full Text] [Related]
32. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830 [TBL] [Abstract][Full Text] [Related]
33. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats. Myers SR; Spinnato JA Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234 [TBL] [Abstract][Full Text] [Related]
34. Amplification of the thymidylate synthase gene in an N10-propargyl-5,8-dideazafolic-acid-resistant human leukemia, MOLT-3 cell line developed in pteroylglutamic acid, but not in leucovorin. Miyachi H; Takemura Y; Kobayashi H; Ando Y J Cancer Res Clin Oncol; 1996; 122(11):659-64. PubMed ID: 8898975 [TBL] [Abstract][Full Text] [Related]
35. The absorption, distribution, and excretion of 14C-penicillic acid by rats. Park DL; Dailey RE; Friedman L; Heath JL Ann Nutr Aliment; 1977; 31(4-6):919-34. PubMed ID: 613942 [TBL] [Abstract][Full Text] [Related]
36. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196 [TBL] [Abstract][Full Text] [Related]
37. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats. Lemaire M; Azria M; Dannecker R; Marbach P; Schweitzer A; Maurer G Drug Metab Dispos; 1989; 17(6):699-703. PubMed ID: 2575511 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics, safety, and efficacy of a liposome encapsulated thymidylate synthase inhibitor, OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] in mice. Desjardins J; Emerson DL; Colagiovanni DB; Abbott E; Brown EN; Drolet DW J Pharmacol Exp Ther; 2004 Jun; 309(3):894-902. PubMed ID: 14982966 [TBL] [Abstract][Full Text] [Related]
39. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]